Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Antibiotic   Cefamandole nafate  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Acemycin Greece
Cefam Hungary, Italy
Cefamandol Luxembourg
Cefamandolo Italy
Cemado Italy
Kefadol Ireland
Kefandol Great Britain, Morocco
Lampomandol Italy
Mancef Italy
Mandokef Austria, Greece, Hungary, Italy, Switzerland
Mandol Australia, Luxembourg, Netherlands, New Zealand, United Arab Emirates
Mandolsan Italy
Septomandolo Italy
Tarcefandol Poland
References   injection   References : Cefamandole nafate  
Type Publication
198 Journal Gayed AA, Kheshary PR, Hinkle RL.
Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
Am J Health-Syst Pharm 1995 ; 52: 516-520.
336 Journal Forman JK, Lachs JR, Souney PF.
Visual compatibility of acyclovir sodium with commonly used intravenous drugs during simulated Y-site injection.
Am J Hosp Pharm 1987 ; 44: 1408-1409.
385 Journal Benedict MK, Roche VF, Banakar UV, Hilleman DE.
Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection.
Am J Hosp Pharm 1988 ; 45: 1117-1118.
405 Journal Nieves-Cordero AL, Luciw HM, Souney PF.
Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1985 ; 42: 1108-1109.
406 Journal Smythe MA, Patel MA, Gasloli RA.
Visual compatibility of narcotic analgesics with selected intravenous admixtures.
Am J Hosp Pharm 1990 ; 47: 819-820.
418 Journal Bosso JA, Townsend RJ.
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Am J Hosp Pharm 1985 ; 42: 2211-2214.
472 Journal Wohlford JG, Fowler MD.
Visual compatibility of hetastarch with injectable critical-care drugs.
Am J Hosp Pharm 1989 ; 46: 995-996.
574 Journal Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.
Stability of antibiotics frozen and stored in disposable hypodermic syringes.
Am J Hosp Pharm 1980 ; 37: 1087-1088.
576 Journal Holmes CJ, Ausman RK, Walter CW, Kundsin RB.
Activity of antibiotic admixtures subjected to different freeze-thaw treatments.
Drug Intell Clin Pharm 1980 ; 14: 353-357.
604 Manufacturer Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
612 Journal Frable RA, Klink PR, Engel GL, Mundell EE.
Stability of cefamandole nafate injection with parenteral solutions and additives.
Am J Hosp Pharm 1982 ; 39: 622-627.
630 Journal Das Gupta V, Stewart KR.
Stability of metronidazole and ten antibiotics when mixed with magnesium sulphate solutions.
J Clin Hosp Pharm 1985 ; 10: 67-72.
999 Journal Watson D.
Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution.
JPEN 1985 ; 9: 220-224.
1035 Journal Bisaillon S, Sarrazin R.
Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion.
J Parenter Sci Technol 1983 ; 37: 129-132.
1047 Journal Souney PF, Colucci RD, Mariani G, Campbell D.
Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection.
Am J Hosp Pharm 1984 ; 41: 323-324.
1057 Journal Cutie MR.
Compatibility of verapamil hydrochloride injection with commonly used additives.
Am J Hosp Pharm 1983 ; 40: 1205-1207.
1165 Journal Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.
Compatibility of the cephalosporin, cefamandole nafate with injections.
Int J Pharm 1980 ; 4: 263-265.
1201 Journal Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.
Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures.
Am J Hosp Pharm 1981 ; 38: 1919-1922.
1232 Journal Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236.
1479 Journal Digel S.
Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion.
Krankenhauspharmazie 1995 ; 1: 9-12.
3520 Manufacturer Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3526 Manufacturer Clindamycin (Dalacin®) - Summary of Product Characteristics
Pharmacia 2010
3546 Manufacturer Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3549 Manufacturer Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3594 Manufacturer Metronidazole (Flagyl®) - Summary of Product Characteristics
Zentiva 2013
3643 Manufacturer Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3644 Manufacturer Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3674 Manufacturer Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
  Mentions Légales